Top Markets
Coin of the day
Stryker Corporation Stryker Corporation

Stryker Corporation

SYK
Classement en actions #160
Stryker Corporation operates as a medical technology company. The company... Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Prix de l'action
$336.84
Capitalisation boursière
$129.13B
Changement (1 jour)
2.00%
Changement (1 an)
-15.94%
Pays
US
Échange Stryker Corporation (SYK)

Catégorie

Ratio P/E pour Stryker Corporation (SYK)
Ratio P/E au July 2026 TTM : 35.63
Selon les derniers rapports financiers et le cours de l'action de Stryker Corporation, le ratio P/E actuel (TTM) est de 35.63. À la fin de l’année 2024, le P/E de l’entreprise était de 45.83.
Historique du ratio P/E pour Stryker Corporation de 2000 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
2026 (TTM) 35.63 -13.89%
2025 41.38 -9.71%
2024 45.83 27.61%
2023 35.92 -8.41%
2022 39.21 -22.44%
2021 50.56 -12.14%
2020 57.54 52.66%
2019 37.69 128.39%
2018 16.50 -70.93%
2017 56.77 108.63%
2016 27.21 11.88%
2015 24.32 -64.92%
2014 69.33 145.16%
2013 28.28 75.92%
2012 16.07 12.53%
2011 14.28 -14.55%
2010 16.72 -7.52%
2009 18.08 27.26%
2008 14.20 -52.79%
2007 30.09 4.28%
2006 28.85 8.62%
2005 26.56 -36.09%
2004 41.57 6.61%
2003 38.99 -3.57%
2002 40.43 -4.42%
2001 42.30 -5.53%
2000 44.78 0.00%
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
24.71 -30.65%
US
21.15 -40.65%
IE
17.76 -50.15%
US
47.67 33.77%
US
30.88 -13.33%
US
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.